Charnwood expands CRO footprint
As part of its expansion plans for this year, Charnwood Molecular, a UK-based pre-clinical discovery CRO to the pharmaceutical and biotechnology market, has become the sole occupier of a three-storey laboratory facility at Charnwood Campus in Loughborough. This is being funded with support from European private equity fund Synova, which recently took a stake in the company.
The expansion will support Charnwood’s growth plan across a wide range of contract research services, the firm said: “from medicinal chemistry, chemical development and early process research through to developing a suite of complementary services in order to provide a holistic pre-clinical discovery portfolio”. It came in response to a “significant expansion” of the client base in recent years.